Dr. Johnson L. Moon, M.D.
Neurology (Neurology Physician)
- Medicare participating
At a glance
- Medical school
- University of Iowa, Rj & L Carver College of Medicine (2002)
- Years since graduation
- 24
- In the NPI registry since
- 2007
- Medicare patients seen, 2024
- 433
Licensed in California since 2004, according to the Medical Board of California. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2002Medical school: University of Iowa, Rj & L Carver College of Medicine
- 2007Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Neurology Physician primary
CA license A86444 (first issued 2004; current) -
Clinical Neurophysiology Physician
CA license A86444 (first issued 2004; current)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Uci Health-Orange Orange, CA
- Providence St. Jude Medical Center Fullerton, CA
- Providence St. Joseph Hospital Orange, CA
Medical groups
- Neurology Center of North Orange County A Medical Corp (5 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 433
- Services billed
- 979
- Patients’ average age
- 77
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 391 | 236 |
| New patient office or other outpatient visit, 45-59 minutes | 132 | 132 |
| Measurement of brain wave activity (eeg), awake and asleep | 50 | 50 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 48 | 34 |
| Measurement of brain wave activity (eeg), awake and drowsy | 47 | 44 |
| Critical care, first 30-74 minutes | 42 | 28 |
| Needle measurement of electrical activity in arm or leg muscles, complete study | 40 | 23 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 32 | 32 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 23 | 16 |
| Established patient office or other outpatient visit, 20-29 minutes | 20 | 20 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Donepezil Hcl Other prescribers in Fullerton, CA | 323 |
| Gabapentin Other prescribers in Fullerton, CA | 197 |
| Carbidopa-Levodopa (carbidopa/levodopa) Other prescribers in Fullerton, CA | 176 |
| Levetiracetam Other prescribers in Fullerton, CA | 156 |
| Memantine Hcl Other prescribers in Fullerton, CA | 146 |
| Topiramate Other prescribers in Fullerton, CA | 129 |
| Galantamine Er (galantamine hbr) Other prescribers in Fullerton, CA | 104 |
| Primidone Other prescribers in Fullerton, CA | 92 |
| Atorvastatin Calcium Other prescribers in Fullerton, CA | 87 |
| Escitalopram Oxalate Other prescribers in Fullerton, CA | 75 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 11 companies reported 34 payments worth $864 in total to this clinician.
| AbbVie Inc. | $251 |
|---|---|
| Abbott Laboratories | $191 |
| Celgene Corporation | $90.88 |
| Novartis Pharmaceuticals Corporation | $88.64 |
| UCB, Inc. | $66.80 |
| Merz Pharmaceuticals, LLC | $57.99 |
| Csl Behring | $35.72 |
| Pfizer Inc. | $26.02 |
| Food and Beverage | $864 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 2 industry-funded studies in 2025, from 2 companies. The companies reported $272,148 in research payments for these studies, mostly to the institutions running them.
- A Randomized, Double-blind, Placebo-controlled, Global Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986446, an Anti-MTBR Tau Monoclonal Antibody, in Participants with Early Alzheimers Disease (Targe…
E.r. Squibb & Sons, L.l.c. - A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE (LIBREXIA-STROK)
Janssen Research & Development, LLC
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.